How to treat oral leucoplakia

Journal of the European Academy of Dermatology and Venereology

Volumn 14, Issue 6, 2000, Pages 446-447

  Laskaris, G ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CARBON DIOXIDE; ETRETIN; ISOTRETINOIN; PROTEIN P53; RETINOIC ACID;

ALCOHOL CONSUMPTION; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; CRYOSURGERY; DISEASE PREDISPOSITION; DRUG FORMULATION; DYSPLASIA; EDITORIAL; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LASER SURGERY; LEUKOPLAKIA; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; SKIN BIOPSY; SKIN DEFECT; SMOKING; SQUAMOUS CELL CARCINOMA;

ACITRETIN; ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; BIOPSY, NEEDLE; CARBOXYMETHYLCELLULOSE; FEMALE; HUMANS; LEUKOPLAKIA; MALE; MOUTH MUCOSA; MOUTH NEOPLASMS; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 0034426624     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2000.00154.x     Document Type: Editorial

References (4)

1. Color Atlas of Oral Diseases
2. 'High risk' HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa
3. Oral leucoplakia and malignant transformation: A follow-up study of 257 patients
4. P53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma